Cargando…
Overcoming multidrug-resistance in vitro and in vivo using the novel P-glycoprotein inhibitor 1416
MDR (multidrug-resistance) represents a major obstacle to successful cancer chemotherapy and is usually accomplished by overexpression of P-gp (P-glycoprotein). Much effort has been devoted to developing P-gp inhibitors to modulate MDR. However, none of the inhibitors on the market have been success...
Autores principales: | Xu, Yan, Zhi, Feng, Xu, Guangming, Tang, Xiaolei, Lu, Sheng, Wu, Jinhui, Hu, Yiqiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497725/ https://www.ncbi.nlm.nih.gov/pubmed/22757751 http://dx.doi.org/10.1042/BSR20120020 |
Ejemplares similares
-
HZ08 Reverse P-Glycoprotein Mediated Multidrug Resistance In Vitro and In Vivo
por: Hu, Zheyi, et al.
Publicado: (2015) -
3.1416 and all that
por: Davis, Philip J, et al.
Publicado: (1985) -
In silico identified targeted inhibitors of P-glycoprotein overcome multidrug resistance in human cancer cells in culture
por: Follit, Courtney A, et al.
Publicado: (2015) -
The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivo
por: Huang, Chixiong, et al.
Publicado: (2018) -
A cell-based high-throughput screen identifies inhibitors that overcome P-glycoprotein (Pgp)-mediated multidrug resistance
por: Zahra, Rida, et al.
Publicado: (2020)